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Background: Neutrophil-to-lymphocyte ratio (NLR) is a marker of systemic inflammation that correlates with
cardiac events. This study assessed the association between NLR and the presence of chronic coronary total
occlusion (CTO).
Methods: The study population included 225 patients, a control group (n = 75), a coronary artery disease group
(n = 75), and a CTO group (n = 75). NLR was compared in the three groups.
Results: NLR levels were significantly higher in the CTO than in the other two groups (p < 0.001). Bivariate correlation
analysis showed a positive correlation between NLR and SYNTAX Score, and multivariate logistic regression analysis
found that NLR was an independent predictor of CTO. ROC analysis showed that an NLR cut-off of 2.09 could
distinguish between patients with and without CTO (AUC = 0.74; 95% CI, 0.68–0.81), with a specificity of 69.3% and a
sensitivity of 61%.
Conclusion: NLR may be useful as a marker of CTO.
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Cardiovascular disease is the major cause of death in
developed countries. Atherosclerosis is a progressive
disease characterized by the accumulation of lipids and
fibrous elements in the large arteries and constitutes the
single most important contributor to the growing bur-
den of cardiovascular disease [1]. Inflammation plays a
key role in the development, progression, and complica-
tions of atherosclerosis. Inflammatory processes inter-
acting with endothelial dysfunction initiate a progressive
process within the arterial wall, resulting in the reduc-
tion or obstruction of blood supply to end organs of the
body including the brain, heart, and intra-abdominal or-
gans, as well as tissues of the lower limbs, causing mor-
bidity and mortality [2-4]. Increased cardiovascular risk
has been found to correlate with counts of white blood
cells (WBC) and subtypes. Neutrophil-to-lymphocyte
ratio (NLR) is a marker of systemic inflammation that
has been found to correlate with mortality and cardiac
events in many cardiovascular diseases such as stable* Correspondence: drkenan76@yahoo.com
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unless otherwise stated.coronary artery disease (CAD), unstable CAD, and acute
decompensated heart failure [5,6].
Chronic coronary total occlusions (CTOs) are gene-
rally considered lesions of duration >3 months in which
the vessel shows either complete interruption of ante-
grade blood flow on angiography or minimal contrast
penetration through the lesion without distal vessel
opacification [7]. CTO, which is present in one third of
patients with coronary diseases, is the end stage of
coronary artery atherosclerosis [8].
The SYNTAX score (SS) provides important information
on favorable revascularization strategy and the prognostic
significance of CAD [9]. NLR may be associated with a
greater complexity of CAD and CTO as assessed using the
SS. Thus, this study was designed to examine whether NLR
is associated with the extent of CAD and CTO.Patients and methods
The study population included 225 patients who were
referred for elective coronary angiography for stable
angina pectoris between August 2013 and April 2014.
All patients recruited in this study underwent coronary
angiography for the presence of chest pain with objectivetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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perfusion scintigraphy). Exclusion criteria were previous
coronary artery bypass grafting (CABG), acute coronary
syndrome, hematological disease, malignancy, severe
renal or liver disease, ongoing infection or chronic
inflammatory disease, and autoimmune disease. Patients
(n = 75) who were considered to have lesions with a
duration of >3 months, in which the vessel shows no
antegrade blood flow on angiography or only minimal
contrast penetration through the lesion without distal
vessel opacification were included in the CTO group.
Patients (n = 75) who had coronary lesion with a diam-
eter stenosis of ≥50% were included in the CAD group,
and those (n = 75) who had normal coronary artery or
coronary lesion with a diameter <50% were included in
the control group. Patients’ laboratory and clinical char-
acteristics, such as age, sex, diabetes mellitus, hyper-
tension, hypercholesterolemia, smoking, and family history
of cardiovascular disease were reported. Hemoglobin,
WBC, platelet, lymphocyte, and neutrophil counts were
measured as part of the automated complete blood count.
Baseline NLR was measured by dividing the neutrophil
count by the lymphocyte count.
Transthoracic echocardiographic examination was
conducted in all patients with Vivid E9 system using a 1.5-
4.6 MHz probe (GE-Vingmed Ultrasound AS, Horten,
Norway) before they were discharged. The left ventricu-
lar ejection fraction was measured using the modified
Simpson rule [10].
SS is an angiographic tool used in grading the complex-
ity of CAD. Each coronary lesion with a diameter stenosis
more than 50% in vessels >1.5 mm must be scored. The
online latest updated version (2.1) was used in the calcula-
tion of the SS (www.syntaxscore.com) [11].
The study was approved by the ethical committee of
Selcuk University, Faculty of Medicine. All participants
also had to give a written consent.
Statistical analysis
SPSS 17.0 for Windows was used for statistical analyses
(SPSS, Chicago, Illinois, USA). Continuous variables were
presented as median or mean ± SD; categorical variables
were defined as percentage. Differences in the continuous
variables between groups were determined using Student’s
t test or the Mann-Whitney U test for variables with or
without normal distribution, respectively. To test the nor-
mal distribution, the Kolmogorov-Smirnov test was used.
Categorical variables were summarized as percentages and
compared with the X2 test. The Pearson correlation co-
efficient was computed to examine the association be-
tween 2 continuous variables. Logistic regression analysis
with “enter” method was performed including independ-
ent variables being significantly different between patients
with CAD and CTO and having a possible causative rolefor CTO. All tests of significance were two tailed. An
exploratory evaluation of additional cut-points was per-
formed using the receiver operating characteristic (ROC)
curve analysis. Statistical significance was defined as
a p value of less than 0.05.
Results
The baseline characteristics of patients are summarized
in Table 1. There were 75 patients (mean age of 58 ± 11,
and 45.3% were male) in the control group, 75 patients
(mean age of 63 ± 10, and 65.3% were male) in the CAD
group, and 75 patients (mean age of 61 ± 8, and 88% were
male) in the CTO group. Mean age was significantly
higher in the CAD group (p = 0.01). The male patient ratio
of CTO and CAD groups were higher than that of the
control group. The prevalence of cardiovascular risk fac-
tors. such as diabetes mellitus, hyperlipidemia, and family
history of CAD, were significantly higher in the CTO
group than in other groups (p = 0.004, p < 0.001, and p <
0.001, respectively), but hypertension and smoking were
similar in all the groups. The groups were similar in terms
of hemoglobin levels and platelet count. WBC and neutro-
phil count were significantly higher in the CTO group; in
contrast, the lymphocyte count was significantly lower in
the CTO group (p = 0.001, p < 0.001, and p = 0.01, respect-
ively). NLR levels were significantly higher in the CTO
group (p < 0.001) (Figure 1). Also, Gensini score and SYN-
TAX score were significantly higher in the CTO group
than in other groups (both p < 0.001).
In the bivariate correlation analyses, there was a
weak positive correlation between NLR and SS (p =
0.05) (Figure 2). And, in the bivariate correlation ana-
lyses, there was a positive correlation between NLR
and Gensini score (p < 0.001) (Figure 3).
In the multivariate logistic regression analysis, NLR,
male sex, hyperlipidemia, and family of history CAD were
identified as independent predictors of CTO in our model
(Table 2).
In ROC analysis, a cut point of 2.09 for NLR was iden-
tified in patients with CTO (area under the curve = 0.74;
95% CI, 0.68-0.81). A NLR value of more than 2.09 demon-
strated a specificity of 69.3% and a sensitivity of 61%
(Figure 4).
Discussion and conclusions
To our knowledge, this study is the first to investigate the
relationship between NLR and CTO. This study found
that NLR levels were significantly higher in the CTO
group, suggesting that high NLR levels may predict CTO
in patients with CAD.
Atherosclerosis is a complex and multifactorial inflamma-
tory disease characterized by low-grade arterial inflamma-
tory lesions that can develop through disease progression
[12]. Previous epidemiological and clinical studies have
Table 1 Baseline clinical characteristic of patients and controls
Control group (n = 75) CAD group (n = 75) CTO group (n = 75) p
Age, years 58 ± 11 63 ± 10 61 ± 8 0.01
Male, n (%) 34 (45.3) 49 (65.3) 66 (88) <0.001
Diabetes mellitus, n (%) 12 (16) 30 (40) 26 (34.7) 0.004
Hypertension, n(%) 50 (66.7) 55 (73.3) 49 (65.3) 0.52
Hyperlipidemia, n (%) 19 (25.3) 44 (58.7) 52 (69.3) <0.001
Family history of CAD, n (%) 2 (2.7) 4 (5.3) 29 (38.7) <0.001
Smoking, n (%) 25 (33.3) 33 (44.4) 39 (52) 0.06
Ejection fraction, % 57.9 ± 7.4 55.1 ± 10 51.3 ± 9.1 <0.001
Hemoglobin, g/dL 14.2 ± 1.6 13.8 ± 1.6 13.7 ± 1.7 0.16
Platelet, 103/ml 233 ± 61 251 ± 75 233 ± 68 0.17
WBC, 103/ml 7.40 ± 1.84 7.93 ± 1.96 8.63 ± 1.94 0.001
Neutrophil, 103/ml 4.16 ± 1.27 4.78 ± 1.36 5.62 ± 1.49 <0.001
Lymphocyte,103/ml 2.46 ± 0.76 2.33 ± 0.67 2.11 ± 0.72 0.01
NLR 1.79 ± 0.57 2.13 ± 0.64 2.95 ± 1.29 <0.001
Gensini score 1.5 (0-13) 26 (2-128) 64 (33.5-158) <0.001
SYNTAX score 10.3 ± 6.8 19.2 ± 7.6 <0.001
CAD, coronary artery disease; CTO, coronary total occlusion; NLR, neutrophil-to-lymphocyte ratio; WBC, white blood cell.
Significant p values are bold.
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counts and the risk of adverse cardiovascular events in
patients with CAD [6]. WBC subtypes have also been
shown to be markers of inflammation in cardiovascular
diseases [13]. NLR is a predictor of severe atheroscler-
osis that may be useful for cardiac risk stratification in
patients with CAD [14]. Several studies have suggestedFigure 1 NLR levels among study groups.that high NLR levels were associated with adverse
outcomes and increased cardiovascular mortality in pa-
tients with stable CAD and acute coronary syndrome
and in those undergoing CABG and primary percutan-
eous coronary intervention [15-18].
The SS is an established anatomical-based tool for
objectively determining the complexity of coronary
Figure 2 Correlation between NLR and SYNTAX score; Pearson test was used.
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to perform CABG surgery or percutaneous coronary
intervention. The SS assesses the importance of a dis-
eased coronary artery segment based on its severity,
anatomical location, and importance in supplying
blood to the myocardium; the SS can also be used toFigure 3 Correlation between NLR and Gensini score; Pearson test waassess bifurcation lesions, and total occlusion charac-
teristics [19]. The Gensini score is another scoring
system used to evaluate collateral circulation in the
coronary arteries [20]. CTO is defined as complete
occlusion of the coronary vessel with TIMI 0 flow,
present for an estimated duration of ≥3 months [21].s used.
Table 2 Predictors of CTO in multivariate logistic
regression analysis
Independent variables β ± SE Wald p
NLR 1.03 ± 0.25 16.74 <0.001
WBC 0.18 ± 0.09 3.79 0.05
Sex -1.36 ± 0.45 9.11 0.003
Hyperlipidemia -0.81 ± 0.38 4.56 0.03
Family history of CAD -2.45 ± 0.55 19.65 <0.001
β ± SE, beta ± Standard error; CAD, Coronary artery disease; NLR, neutrophil-to-
lymphoycte ratio; WBC, white blood cell.
Significant p values are bold.
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been reported associated with the extent and severity of
CAD [22]. Additionally, WBC and neutrophil counts
were found to be higher in patients with high than low
SS [23,24]. High SS has been found to be predict poorer
short and long-term clinical outcomes in patients with
CAD who underwent revascularization [25]. Increased
NLR, widely recognized as an indicator of systemic in-
flammation, has been associated with higher mortality
rates (Papa et al) [15]. Moreover, NLR has been found to
correlate with the severity and complexity of CAD,
assessed by SS in stable patients with CAD (Kaya et al.)
[26], and higher NLR at baseline was found to be inde-
pendently associated with greater coronary complexity
of CAD as assessed by SS (Sönmez et al.) [9]. In this
study, both Gensini score and SS were significantly
higher in the CTO than in the CAD group, with bivari-
ate correlation analysis showing a weak positive correl-
ation between NLR and SS.Figure 4 Receiver–operating characteristic analysis and curve
for predicting coronary total occlusions (CTOs).Arterial CTOs in the coronary and peripheral vascula-
ture are common and are associated with significant mor-
bidity and adverse outcomes [27]. CTO develops from
total luminal obstruction of an artery by a thrombus, with
subsequent organization and varying degrees of recanali-
zation; often, these events are clinically silent. The process
of thrombus organization coincides with the development
of intraluminal microvessels accompanied by inflamma-
tory cells, followed by infiltrating smooth muscle cells and
deposition of proteoglycan matrix [28]. In CTOs of all
ages, a close relation in both location and intensity has
been observed between cellular inflammation and vessel
wall neovascularization [29]. NLR is an indicator of in-
flammatory status that can easily be derived from the
WBC count. Moreover, higher NLR has been correlated
with the development of poor coronary collateral circula-
tion in patients with CTO (Kalkan et al.) [30]. To our
knowledge, our study is the first to evaluate NLR levels in
controls, patients with CAD, and patients with CTO, find-
ing that NLR levels were significantly higher in the CTO
than in the other groups. An optimal NLR cut off value of
2.09 was found to predict CTO with a specificity of 69.3%
and a sensitivity of 61%. Moreover, multivariate logistic re-
gression analysis showed that NLR was an independent
predictor of CTO. These findings indicate that measure-
ments of NLR, a novel cardiovascular risk marker, is an
important, simple, and inexpensive method of screening
for CTO prior to the performance of other expensive and
invasive procedures.
The major limitations of our study include the small
patient population and the lack of measured inflamma-
tory markers. Moreover, our exclusion criteria prevent
the extrapolation of our findings to other populations
with these co-morbid conditions.
In conclusion, NLR may predict the presence of CTO,
but additional studies with more patients are required to
confirm this result.
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